Amar Patel, MD
Celgene
5
0
3
N/A
0
5
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+1 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (5)
Research Network
Collaboration Network
Research Areas & Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Bradley J. Monk, MD
St. Joseph's Hospital and Medical Center, Phoenix AZ
Shared therapeutic areas:
Worked with same sponsors:
Ezra Cohen, MD
University of Chicago
Shared therapeutic areas:
Worked with same sponsors:
Robert Ferris, MD, PhD
University of Pittsburgh
Shared therapeutic areas:
Worked with same sponsors:
Alice P Chen, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
David Avigan, MD
Beth Israel Deaconess Medical Center
Shared therapeutic areas:
Hagop Youssoufian, MD
Verastem, Inc.
Shared therapeutic areas:
Soo Chin Lee
National University Hospital, Singapore
Shared therapeutic areas:
Brigitte C Widemann, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Gary Schiller, MD
University of California, Los Angeles
Shared therapeutic areas:
Corey J. Langer, MD
Fox Chase Cancer Center
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (5)
Showing 5 of 5 trials
A Phase Ib Study of Neoadjuvant of Cetuximab Plus Motolimod and Cetuximab Plus Motolimod Plus Nivolumab
Chemotherapy Plus Cetuximab in Combination With VTX-2337 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Safety and Pharmacologic Study of VTX-2337 in Patients With Advanced Cancer
VTX-2337 in Combination With Radiotherapy in Patients Low-Grade B-cell Lymphomas
All 5 trials loaded